博拓生物
(688767)
| 流通市值：35.06亿 | | | 总市值：35.06亿 |
| 流通股本：1.07亿 | | | 总股本：1.07亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,610,085,475.64 | 1,565,595,867.47 | 1,765,904,542.46 | 1,907,430,695.68 |
| 应收票据及应收账款 | 83,185,165.87 | 68,531,418.69 | 60,565,920.29 | 61,888,543.95 |
| 应收账款 | 83,185,165.87 | 68,531,418.69 | 60,565,920.29 | 61,888,543.95 |
| 预付款项 | 1,543,183.91 | 1,271,885.94 | 1,961,065.57 | 1,306,934.64 |
| 其他应收款合计 | 1,480,711.18 | 44,335,769.36 | 3,392,848.66 | 2,796,215.41 |
| 存货 | 76,257,370.96 | 80,459,595.31 | 81,513,475.04 | 99,323,982.27 |
| 一年内到期的非流动资产 | - | 0 | - | 10,000,000 |
| 其他流动资产 | 61,345,177.52 | 1,884,165.67 | 5,861,397.5 | 4,061,685.92 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,834,897,085.08 | 1,862,078,702.44 | 1,919,199,249.52 | 2,086,808,057.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,203,087.57 | 2,377,090.28 | 2,553,965.42 | 2,840,500.33 |
| 投资性房地产 | 4,730,192.8 | 4,798,618.52 | 4,856,010.76 | 4,931,115.87 |
| 固定资产 | 371,552,109.26 | 378,167,990.77 | 383,339,067.77 | 220,573,094.57 |
| 在建工程 | 97,248,733.73 | 49,941,029.95 | 39,763,629.07 | 39,654,454.76 |
| 使用权资产 | 21,979.4 | 61,979.4 | 693,210.71 | 1,349,421.63 |
| 无形资产 | 204,311,221.91 | 205,802,521.91 | 207,368,231.41 | 208,709,743.09 |
| 长期待摊费用 | 26,778.78 | 54,470.13 | 81,340.63 | 108,266.15 |
| 递延所得税资产 | 10,286,009.38 | 12,925,735.57 | 14,791,801.98 | 14,442,223.54 |
| 其他非流动资产 | 4,451,102.84 | 2,757,750 | 1,537,300 | 153,378.29 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 694,831,215.67 | 656,887,186.53 | 654,984,557.75 | 492,762,198.23 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,529,728,300.75 | 2,518,965,888.97 | 2,574,183,807.27 | 2,579,570,256.1 |
| 流动负债: | | | | |
| 短期借款 | 299,027.2 | 522,443.97 | 347,555.03 | 588,768.99 |
| 应付票据及应付账款 | 59,443,976.79 | 60,213,838.06 | 56,813,724.17 | 58,353,267.93 |
| 应付账款 | 59,443,976.79 | 60,213,838.06 | 56,813,724.17 | 58,353,267.93 |
| 合同负债 | 46,681,502.68 | 41,529,746.29 | 44,656,651.08 | 47,155,882.37 |
| 应付职工薪酬 | 14,166,901.94 | 12,277,288.36 | 10,158,497.68 | 17,610,860.61 |
| 应交税费 | 2,048,997.54 | 5,249,190.44 | 5,387,075.99 | 3,139,326.09 |
| 其他应付款合计 | 16,949,817.68 | 19,832,936.48 | 21,766,990.1 | 19,621,102.85 |
| 一年内到期的非流动负债 | 445,276.47 | 1,128,308.7 | 1,791,133.53 | 2,450,197.1 |
| 其他流动负债 | 268,028.11 | 204,948.79 | 203,336.97 | 506,258.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 140,303,528.41 | 140,958,701.09 | 141,124,964.55 | 149,425,664.64 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | - | 0 |
| 递延收益 | 10,653,558.66 | 10,996,250.6 | 11,338,942.55 | 8,686,884.48 |
| 递延所得税负债 | - | 708,330.62 | 708,330.62 | 708,330.62 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 10,653,558.66 | 11,704,581.22 | 12,047,273.17 | 9,395,215.1 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 150,957,087.07 | 152,663,282.31 | 153,172,237.72 | 158,820,879.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 106,666,667 | 106,666,667 | 106,666,667 | 106,666,667 |
| 资本公积 | 813,332,050.99 | 813,332,050.99 | 813,332,050.99 | 813,332,050.99 |
| 减:库存股 | 57,944,777.24 | 56,934,967.8 | 54,292,506.12 | 14,764,220.79 |
| 其他综合收益 | -2,201,509.16 | 566,686.55 | -105,760.44 | -355,939.32 |
| 盈余公积 | 53,333,333.5 | 53,333,333.5 | 53,333,333.5 | 53,333,333.5 |
| 未分配利润 | 1,462,597,850.95 | 1,445,561,226.77 | 1,496,662,941.37 | 1,457,031,592.78 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,375,783,616.04 | 2,362,524,997.01 | 2,415,596,726.3 | 2,415,243,484.16 |
| 少数股东权益 | 2,987,597.64 | 3,777,609.65 | 5,414,843.25 | 5,505,892.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,378,771,213.68 | 2,366,302,606.66 | 2,421,011,569.55 | 2,420,749,376.36 |
| 负债和股东权益合计 | 2,529,728,300.75 | 2,518,965,888.97 | 2,574,183,807.27 | 2,579,570,256.1 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |